These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22854528)

  • 1. Innovative technologies for SFA occlusions: drug coated balloons in SFA lesions.
    Minar E; Schillinger M
    J Cardiovasc Surg (Torino); 2012 Aug; 53(4):481-6. PubMed ID: 22854528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of Legflow(®) paclitaxel eluting balloon and stenting versus standard percutaneous transluminal angioplasty and stenting for the treatment of intermediate and long lesions of the superficial femoral artery (RAPID trial): study protocol for a randomized controlled trial.
    Karimi A; de Boer SW; van den Heuvel DA; Fioole B; Vroegindeweij D; Heyligers JM; Lohle PN; Elgersma O; Nolthenius RP; Vos JA; de Vries JP
    Trials; 2013 Mar; 14():87. PubMed ID: 23537403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions.
    Zeller T; Rastan A; Macharzina R; Tepe G; Kaspar M; Chavarria J; Beschorner U; Schwarzwälder U; Schwarz T; Noory E
    J Endovasc Ther; 2014 Jun; 21(3):359-68. PubMed ID: 24915582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standard balloon angioplasty versus angioplasty with paclitaxel-eluting balloons for femoropopliteal artery stenosis.
    Ju MH; Rodríguez HE
    J Cardiovasc Surg (Torino); 2012 Aug; 53(4):459-63. PubMed ID: 22854525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of a paclitaxel-eluting balloon for treatment of femoropopliteal arterial disease: 12-month results from a multicenter Italian registry.
    Micari A; Cioppa A; Vadalà G; Castriota F; Liso A; Marchese A; Grattoni C; Pantaleo P; Cremonesi A; Rubino P; Biamino G
    JACC Cardiovasc Interv; 2012 Mar; 5(3):331-8. PubMed ID: 22440500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-eluting balloons for the treatment of the superficial femoral artery in-stent restenosis: 2-year follow-up.
    Virga V; Stabile E; Biamino G; Salemme L; Cioppa A; Giugliano G; Tesorio T; Cota L; Popusoi G; Pucciarelli A; Esposito G; Trimarco B; Rubino P
    JACC Cardiovasc Interv; 2014 Apr; 7(4):411-5. PubMed ID: 24630884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A network meta-analysis of randomized controlled trials comparing treatment modalities for de novo superficial femoral artery occlusive lesions.
    Antonopoulos CN; Mylonas SN; Moulakakis KG; Sergentanis TN; Sfyroeras GS; Lazaris AM; Kakisis JD; Vasdekis SN
    J Vasc Surg; 2017 Jan; 65(1):234-245.e11. PubMed ID: 27865639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty.
    Marmagkiolis K; Hakeem A; Choksi N; Al-Hawwas M; Edupuganti MM; Leesar MA; Cilingiroglu M
    Catheter Cardiovasc Interv; 2014 Oct; 84(4):555-64. PubMed ID: 24740749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological features of restenosis associated with paclitaxel drug-coated balloon: implications for therapy.
    Krishnan P; Purushothaman KR; Purushothaman M; Tarricone A; Chen S; Singla S; Purushottam B; Kini A; Sharma S; Moreno PR
    Cardiovasc Pathol; 2019; 43():107139. PubMed ID: 31437716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-year results of paclitaxel-eluting balloons for femoropopliteal artery disease: evidence from a multicenter registry.
    Micari A; Cioppa A; Vadalà G; Castriota F; Liso A; Marchese A; Grattoni C; Pantaleo P; Cremonesi A; Rubino P; Biamino G
    JACC Cardiovasc Interv; 2013 Mar; 6(3):282-9. PubMed ID: 23517840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary stenting of the superficial femoral and popliteal artery.
    Dearing DD; Patel KR; Compoginis JM; Kamel MA; Weaver FA; Katz SG
    J Vasc Surg; 2009 Sep; 50(3):542-7. PubMed ID: 19540706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new paclitaxel-eluting balloon for angioplasty of femoropopliteal obstructions: acute and midterm results.
    Micari A; Cioppa A; Vadalà G; Stabile E; Castriota F; Pantaleo P; Grattoni C; Cremonesi A; Marchese A; Rubino P; Biamino G
    EuroIntervention; 2011 May; 7 Suppl K():K77-82. PubMed ID: 22027734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-eluting balloons for femoropopliteal lesions show better performance in de novo stenosis or occlusion than in restenosis.
    Herten M; Torsello GB; Schönefeld E; Imm B; Osada N; Stahlhoff S
    J Vasc Surg; 2015 Feb; 61(2):394-9. PubMed ID: 25307133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How should I treat a restenosis after superficial femoral artery stenting?
    Fusaro M; Cassese S; Byrne RA
    EuroIntervention; 2013 Mar; 8(11):1342-5. PubMed ID: 23538161
    [No Abstract]   [Full Text] [Related]  

  • 15. Paclitaxel-coated versus plain old balloon angioplasty for the treatment of infrainguinal arterial disease in diabetic patients: the Belgian diabetic IN.PACT Trial.
    Debing E; Aerden D; Vanhulle A; Gallala S; von Kemp K;
    J Cardiovasc Surg (Torino); 2017 Aug; 58(4):528-534. PubMed ID: 27727202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving modalities for femoropopliteal interventions.
    Ansel GM; Lumsden AB
    J Endovasc Ther; 2009 Apr; 16(2 Suppl 2):II82-97. PubMed ID: 19624076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasculitis resulting from a superficial femoral artery angioplasty with a paclitaxel-eluting balloon.
    Thomas SD; McDonald RR; Varcoe RL
    J Vasc Surg; 2014 Feb; 59(2):520-3. PubMed ID: 23642919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-eluting balloon catheters for lower limb peripheral arterial disease: the evidence to date.
    Barkat M; Torella F; Antoniou GA
    Vasc Health Risk Manag; 2016; 12():199-208. PubMed ID: 27274265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prime time for drug eluting balloons in SFA interventions?
    Brodmann M
    J Cardiovasc Surg (Torino); 2014 Aug; 55(4):461-4. PubMed ID: 24941235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug eluting balloons.
    Diehm NA; Hoppe H; Do DD
    Tech Vasc Interv Radiol; 2010 Mar; 13(1):59-63. PubMed ID: 20123434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.